A significant development in vaccine distribution is expected to increase access to protection for infants worldwide. Respiratory illness and hospitalization caused by a common virus affect millions of young children annually. The virus is responsible for a substantial number of deaths among children under 5 years old, with a disproportionate number occurring in very young infants.

Further action has been taken to make vaccination more affordable and easier to administer. This builds on earlier decisions regarding vaccine distribution and programming. Details of the vaccine programme and its goals are available from the source.